Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Paul Dendale ,
Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomized clinical trials: insights from 33 prospective stent trials in Europe. Vranckx P, Boersma E, Garg S, Valgimigli M, Van Es GA, Goedhart D, Serruys PW EuroIntervention. 2011 Nov 15;7(7):859-71. doi: 10.4244/EIJV7I7A134
This paper published in a high level interventional journal focuses on the evolution of coronary risk factors over time. By analysing more than 10.000 patients enrolled in coronary stent trials in three time periods (1995-97, 1998-2002 and 2003-2206), the evolution of risk factors could be studied. As expected, diabetes type II increased significantly from 16 to 25% over this time period, but overweight did not show a significant trend (69-70%). The proportion of smokers and patients with hypertension remained constant at approximately 25 and 50% respectively, but cholesterol levels decreased (probably due to statin treatment). The authors conclude rightly that there is an unmet clinical need for prevention in Europe, and that the act of performing a PCI should “open the door towards optimising secondary prevention”. This is as well a call for more cardiac rehabilitation after PCI : most studies show that inclusion in CR is low after PCI, even though the results are as good as after surgery. Now, it remains only to convince our interventional colleagues: this paper may help in this regard.
© 2017 European Society of Cardiology. All rights reserved